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Introduction
To maintain genome stability, DNA replication occurs only once 
in each cell cycle. This is achieved by the cell cycle–dependent 
licensing control that permits assembly of prereplication complexes 
(pre-RCs) at replication origins only once per cell cycle (Mendez 
and Stillman, 2003; Diffl  ey, 2004; Nishitani and Lygerou, 2004; 
Blow and Dutta, 2005; Arias and Walter, 2007). On exit from 
metaphase, the minichromosome maintenance (MCM) 2–7 com-
plex is recruited to replication origins to establish pre-RCs. Once 
replication is activated by the Cdks and Cdc7/Dbf4 kinase, pre-
RCs are disassembled and the reassociation of MCM proteins 
with origins is not permitted until the completion of mitosis.
Regulation of Cdt1 activity during the cell cycle is criti-
cal for the prevention of reassembly of pre-RCs within a single 
cell cycle (Blow and Dutta, 2005; Arias and Walter, 2007). 
When cells enter S phase, Cdt1 is ubiquitinated and degraded 
  (Nishitani et al., 2001; Li et al., 2003; Zhong et al., 2003; Arias 
and Walter, 2005), and this cell cycle–regulated Cdt1 degra-
dation is important for the prevention of rereplication. In the 
Xenopus laevis cell free system, the addition of Cdt1 in G2 ex-
tracts induces rereplication, which is enhanced in the absence of 
geminin (Arias and Walter, 2005; Li and Blow, 2005; Maiorano 
et al., 2005; Yoshida et al., 2005). In mammalian cells, over-
expression of Cdt1 promotes substantial rereplication in certain 
tumor cell lines (Vaziri et al., 2003; Melixetian et al., 2004; Zhu 
et al., 2004).
Rereplication of the genome, or even a segment of it, 
could initiate gene amplifi  cation and cause chromosomal trans-
location and loss, contributing to the tumorigenesis process. 
It has been shown that cell cycle checkpoints are activated when 
rereplication is induced (Machida and Dutta, 2005). In yeast, 
rereplication leads to accumulation of extensive double-stranded 
breaks (DSBs) and activates checkpoints (Archambault et al., 
2005; Green and Li, 2005). In the X. laevis cell free system, 
a caffeine-sensitive phosphorylation of Chk1 occurs when 
rereplication is induced (Li and Blow, 2005). In mammalian 
cells, overexpression of Cdt1 or the loss of geminin activates 
the G2/M checkpoint or induces apoptosis (Vaziri et al., 2003; 
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Melixetian et al., 2004; Zhu and Dutta, 2006). Recently, by using 
X. laevis egg extracts, it was demonstrated that extensive re-
replication, but not a single round of rereplication, leads to 
head-to-tail collision of rereplicating forks resulting in DNA 
fragmentation and checkpoint activation (Davidson et al., 2006). 
This fi   nding suggests an important mechanism underlying 
checkpoint activation when uncontrolled rereplication is induced. 
However, other mechanisms that do not require extensive re-
replication likely exist. In mammalian cells, when licensing 
control is disrupted by Cdt1 overexpression, intriguingly, exten-
sive rereplication only occurs in certain tumor cell lines (Vaziri 
et al., 2003; Tatsumi et al., 2006; this paper). In primary cell 
lines and several tumor cell lines, signifi  cant rereplication is 
not induced but checkpoints are activated.
Two protein kinases, ataxia telangiectasia mutated (ATM) 
and ataxia telangiectasia and Rad3 related (ATR), play critical 
roles in sensing abnormal DNA structures and initiating signal 
transduction in the checkpoint pathways (Abraham, 2001; Shiloh, 
2001). Although related, ATM and ATR respond to DNA dam-
age in overlapping but distinct pathways. ATM responds mainly 
to DSBs, whereas ATR is activated by various kinds of DNA 
damage, including UV and hydroxyurea treatment, which stall 
replication forks. ATR activation requires DNA replication, which 
is different from ATM activation (Michael et al., 2000; Lupardus 
et al., 2002; Tercero et al., 2003).
In this study, we demonstrated that in mammalian cells, 
the ATR-mediated S phase checkpoint is activated at the onset 
of rereplication before the appearance of DSBs. This ATR-
  mediated S phase checkpoint acts directly to inhibit rereplication 
so that signifi  cant rereplication is prevented in the cell lines 
with an intact ATR pathway. We also demonstrated that un-
controlled DNA unwinding initiated by MCM proteins from 
relicensed origins leads to single-stranded DNA (ssDNA) ac-
cumulation, revealing an important mechanism underlying 
checkpoint activation in the absence of extensive rereplication. 
Unlike ATR, ATM does not play critical roles in the prevention 
of rereplication but coordinates with ATR to activate the G2/M 
checkpoint. Finally, we identifi  ed important effector proteins, 
including RPA2 and retinoblastoma protein (Rb), downstream 
of ATR to mediate the inhibition of rereplication. We propose 
that specifi  c defects in the ATR-mediated S phase checkpoint 
pathways present in certain tumor cell lines contribute to their 
susceptibility to rereplication.
Results
ATR plays a critical role in the prevention 
of rereplication
In mammalian cells, when licensing control is disrupted by 
Cdt1/Cdc6 overexpression, it is intriguing that substantial 
  rereplication occurs only in certain tumor cell lines but not in 
primary cell lines and several other tumor cell lines (Vaziri et al., 
2003; Tatsumi et al., 2006). Although p53 is involved (Vaziri 
et al., 2003), the loss of geminin-induced rereplication occurs in 
a p53-independent manner (Melixetian et al., 2004; Zhu et al., 
2004), suggesting that pathways other than p53 are also impor-
tant for preventing rereplication.
Consistent with previous fi  ndings (Vaziri et al., 2003; 
  Tatsumi et al., 2006), we observed that overexpression of Cdt1 
by adenovirus infection was suffi  cient to induce DNA rereplication 
in H1299, HeLa, and U2OS tumor cells, but failed to cause 
overt rereplication in many other cell lines, including primary 
cell lines IMR90 and WI38 and tumor cell lines T98G and A549 
(Fig. 1 A). By using a higher titer of Ad-Cdt1 viruses, Cdt1 over-
expression levels in these rereplication-susceptible cell lines 
were similar to those in U2OS and H1299 cell lines (Fig. 1 A 
and not depicted). Co-overexpression of Cdc6 with Cdt1 also 
failed to induce overt rereplication in T98G, A549, and IMR90 
cells, although it enhanced Cdt1-induced rereplication in U2OS 
and H1299 cells (Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200704138/DC1; and not depicted).
Although extensive rereplication was not observed in 
T98G, A549, and IMR90 cells, checkpoints were activated after 
Cdt1 overexpression. Chk1 and 2 were both phosphorylated 
upon Ad-Cdt1 infection in an ATR- and ATM-dependent manner, 
respectively (Fig. 1 B), although the phosphorylation levels in 
IMR90 and A549 were reduced compared with H1299 and U2OS 
cells, where rereplication was achieved extensively (Fig. 1 B, 
left; and not depicted). These data suggest that both the ATM–
Chk2 and ATR–Chk1 pathways are activated when Cdt1 is over-
expressed, even in the absence of extensive rereplication, although 
overt rereplication may amplify damage signals and enhance 
checkpoint activation.
The critical role of cell cycle checkpoint activation is to 
maintain genome stability. The observation that ATR and ATM 
were activated by Cdt1 overexpression in the cell lines without 
extensive rereplication prompted us to examine whether check-
point activation in fact prevented rereplication. Because Cdt1 
overexpression–induced ATR and ATM activation was observed 
in rereplication-susceptible cell lines such as U2OS and H1299 
(Fig. 1 B), we anticipated that defects allowing rereplication in 
these cell lines were present at the effector pathways downstream 
of ATR and/or ATM. We fi  rst examined rereplication levels in 
U2OS cells when the expression of ATR or ATM was sup-
pressed by short hairpin RNA (shRNA). If the susceptibility of 
U2OS cells to Cdt1-induced rereplication was indeed caused by 
a defect in one branch of the ATR and/or ATM pathways, inacti-
vation of ATR and/or ATM would infl  uence multiple pathways, 
thereby leading to more severe rereplication after Cdt1 over-
expression. We used a low titer of Ad-Cdt1 viruses, which did not 
induce obvious rereplication in U2OS cells. Interestingly, when 
ATR-shRNA was expressed, robust rereplication was induced 
  after Ad-Cdt1 infection, whereas inhibition of ATM did not lead 
to more rereplication (Fig. 2 A). The Cdt1 expression levels were 
similar in all the cell lines that were examined (Fig. 2 A, bottom). 
Consistently, inhibition of endogenous ATR kinase activity 
by overexpressing kinase-dead (KD) Flag-ATR in U2OS cells 
(Nghiem et al., 2002) also led to higher levels of DNA rereplica-
tion after Ad-Cdt1 infection (Fig. 2 B). As an alternative ap-
proach, we inactivated DDB1 and Cdt2, the components of a Cul4 
ubiquitin ligase that are required for Cdt1 ubiquitination and degra-
dation (Hu et al., 2004; Jin et al., 2006) by shRNA in U2OS cells. 
Silencing the expression of DDB1 or Cdt2 leads to detectable accu-
mulation of Cdt1 (1.5- to 2-fold more) and rereplication (Fig. 2 C). S PHASE CHECKPOINT INHIBITS REREPLICATION • LIU ET AL. 645
Inactivation of ATR by shRNAs before the depletion of DDB1 or 
Cdt2 signifi  cantly enhanced the rereplication levels compared 
with vector-infected, ATR-profi  cient cells. Collectively, these 
data suggest that ATR, but not ATM, plays an important role in 
the suppression of DNA rereplication.
We then tested whether ATR is required to prevent re-
replication in the cell lines that are resistant to Cdt1-induced 
rereplication. Strikingly, when ATR activity was inhibited in 
IMR90, WI38, A549, and T98G cell lines by shRNAs, a signif-
icant amount of cells underwent rereplication after Cdt1 or 
Cdt1/Cdc6 was overexpressed (Fig. 2 D and not depicted). 
Therefore, ATR acts as a critical barrier in these cell lines to 
 resist Cdt1-induced rereplication. In contrast, inhibition of ATM 
activity did not disrupt the cellular control that prevents re-
replication (Fig. 2 D). These results uncover a critical function of 
ATR in the prevention of rereplication, especially when licensing 
control is impaired.
Chk1 and 2 are two effector protein kinases downstream of 
ATR and ATM, respectively. We suppressed the expression of 
Chk1 and 2 in multiple cell lines and examined the levels of re-
replication after Cdt1 overexpression. Inactivation of Chk1, but not 
Chk2, signifi  cantly increased the rereplication levels in U2OS cells 
and also led to rereplication in A549 cells, which were normally 
resistant to Cdt1-induced rereplication (Fig. 2 E). These data 
support the fi  nding that the ATR–Chk1 pathway, not the ATM–
Chk2 pathway, is involved in the suppression of rereplication.
Activation of the ATR–Chk1 pathway 
occurs before that of the ATM–Chk2 
pathway when Cdt1 is overexpressed
During DNA rereplication, both DSBs and ssDNA are accumu-
lated (Melixetian et al., 2004; Archambault et al., 2005; Green 
and Li, 2005; Davidson et al., 2006; Zhu and Dutta, 2006). 
We observed that DNA lesions were also accumulated in the 
cell lines where Cdt1 overexpression failed to induce signifi  cant 
rereplication. In every cell line tested, RPA1 and 2 were loaded 
onto chromatin when Cdt1 was overexpressed, suggesting that 
ssDNA accumulated on chromatin (Fig. 3 A). RPA2 was also 
phosphorylated on chromatin, revealed by the presence of 
slower migrating forms of RPA2 (Fig. 3 A). The presence of 
ssDNA was confi  rmed by BrdU immunostaining under non-
denaturing conditions (Fig. 3 B). Likewise, we also detected 
H2AX phosphorylation, a common marker for indicating DSBs 
(Burma et al., 2001), in the cell lines without obvious rereplica-
tion, including IMR90, T98G, and A549 cells (Fig. 3 C and not 
depicted). These data suggest that Cdt1 overexpression leads to 
the generation of both ssDNA and DSBs even in the absence of 
extensive rereplication.
Figure 1.  Cdt1 overexpression leads to checkpoint activation in the absence of detectable rereplication. (A) H1299, U2OS, T98G, and IMR90 cells were 
infected by adenoviruses encoding GFP (Ad-Vec) or human Cdt1 (Ad-Cdt1) with the indicated viral titers: H1299 (10
7 pfu/ml, MOI = 5; or 5 × 10
7 pfu/ml, 
MOI = 25), U2OS (3 × 10
7 pfu/ml, MOI = 15; or 10
8 pfu/ml, MOI = 50), T98G (6 × 10
8 pfu/ml, MOI = 460), and IMR90 (6 × 10
8 pfu/ml, MOI = 600). 
The cell cycle proﬁ  le was analyzed by FACS analysis 48 h after adenovirus infection. The percentage of cells containing more than 4 N of DNA content 
is indicated in each panel. The Cdt1 expression levels are shown by Western blot analysis using the same amount of cell lysates. (B) Cell extracts were pre-
pared from H1299 (5 × 10
7 pfu/ml, MOI = 25), A549 (6 × 10
8 pfu/ml, MOI = 400), U2OS (5 × 10
7 pfu/ml, MOI = 25), and IMR90 (6 × 10
8 pfu/ml, 
MOI = 600) cells (left) or from IMR90 cells expressing shRNA speciﬁ  c for ATR or ATM (middle and right) 48 h after adenoviral infection with Ad-Vec or 
Ad-Cdt1. Western blot analyses were performed using antibodies as indicated. p-Chk1, phosphorylation at S317; p-Chk2, phosphorylation at T68.JCB • VOLUME 179 • NUMBER 4 • 2007  646
Figure 2.  Inactivation of ATR but not ATM leads to enhanced rereplication after Cdt1 overexpression. (A) U2OS cells expressing ATM-shRNA, ATR-shRNA, 
or vector MKO were infected with Ad-vec (GFP) or Ad-Cdt1 (2 × 10
7 pfu/ml, MOI = 10), and FACS analysis was performed 48 h after infection (top). 
Cdt1 overexpression was shown by Western blot analysis (bottom). Actin was used as a loading control. (B) U2OS cell lines carrying tet-on Flag-ATR wild 
type or Flag-ATR-KD were treated with 1 μg/ml doxycyclin 24 h before Ad-vec or Ad-Cdt1 (5 × 10
7 pfu/ml, MOI = 25) infection. FACS analysis was per-
formed 48 h after adenoviral infection. The expression of Cdt1 was shown by Western blot analysis. (C) U2OS cells were infected with retroviruses encod-
ing ATR-shRNA or a vector, followed by inactivation of DDB1 or Cdt2 by shRNA. A week later, after drug selection to enrich shRNA-DDB1– or 
shRNA-Cdt2–expressing cells, FACS analysis was performed (left). The expression of Cdt1 and DDB1 was examined by Western blot analysis (right). 
(D) ATR or ATM was silenced by expressing shRNAs in A549, T98G, and IMR90 cells. FACS analysis was performed 48 h after indicated adenoviral infec-
tion. Western blot analyses were performed as indicated. (E) The expression of Chk1 and 2 was inhibited by expressing shRNA in U2OS and A549 cells 
and revealed by Western blot analysis. FACS analysis was performed 48 h after Ad-vec or Ad-Cdt1 infection. The adenovirus titers U2OS (2 × 10
7 pfu/ml, 
MOI = 10) and A549 (6 × 10
8 pfu/ml, MOI = 400) were used. Black lines indicate that intervening lanes have been spliced out.S PHASE CHECKPOINT INHIBITS REREPLICATION • LIU ET AL. 647
To investigate how DNA lesions were generated when Cdt1 
was overexpressed, we performed a time course analysis to 
monitor the accumulation of ssDNA and DSBs. When a lower 
titer of Ad-Cdt1 was used, a slower kinetics of Cdt1 overexpression 
and Chk1 activation was observed than when a higher titer of 
Ad-Cdt1 was used (Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200704138/DC1). Therefore, to clearly demon-
strate the temporal order of ssDNA and DSB accumulation and 
checkpoint activation, we used the low titer of Ad-Cdt1 or Ad-vec 
(5 × 10
7 pfu/ml, MOI = 25) to infect U2OS cells. At the 12-h 
time point (4 h after signifi  cant Cdt1 expression), although no ob-
vious rereplication was detected (Fig. 3 D, bottom), Chk1 was 
Figure 3.  Cdt1 overexpression–induced rereplication leads to the accumulation of ssDNA and DSBs. (A) H1299 (5 × 10
7 pfu/ml, MOI = 25), A549 
(6 × 10
8 pfu/ml, MOI = 400), U2OS (5 × 10
7 pfu/ml, MOI = 25), T98G (6 × 10
8 pfu/ml, MOI = 460), and IMR90 (6 × 10
8 pfu/ml, MOI = 600) 
cells were infected with Ad-vec or Ad-Cdt1. Chromatin and cell lysates were prepared 48 h after infection. Western blot analyses were performed as indi-
cated. (B) IMR90 cells were infected with Ad-vec or Ad-Cdt1 (6 × 10
8 pfu/ml, MOI = 600) for 48 h and cells were labeled with BrdU during the last 24 h 
of infection. Cells were ﬁ  xed under nondenaturing condition and stained with anti-BrdU antibodies. DAPI was used for nuclear staining. Cells treated with 
0.5 μg/ml DNase 1 before ﬁ  xing were used as a positive control. Similar experiments were performed using U2OS cells. The percentage of BrdU-positive 
cells after Ad-Cdt1 infection in IMR90 and U2OS cells is indicated. Bar, 20 μm. (C) Cell extracts were prepared from H1299, A549, U2OS, and IMR90 
cells 48 h after Ad-vec or Ad-Cdt1 infection as described in A. Western blot analysis was performed using antibody recognizing γ-H2AX. Actin was used 
as a loading control. (D) Chromatin and cell lysates were prepared at different time points after U2OS cells were infected with Ad-vec or Ad-Cdt1 (5 × 10
7 pfu/ml, 
MOI = 25). Western blot analyses were performed as indicated. Phospho-Chk1, phosphorylated at S317; phospho-Chk2, phosphorylated at T68; 
un-RPA2, unphosphorylated RPA2; p-RPA2, phosphorylated RPA2. Cell cycle proﬁ  les were shown at different time points after Ad-vec or Ad-Cdt1 infection. 
Black lines indicate that intervening lanes have been spliced out. JCB • VOLUME 179 • NUMBER 4 • 2007  648
already phosphorylated at the ATR phosphorylation site S317 
(Fig. 3 D, left). At an approximately similar time, RPA chromatin 
loading was observed (Fig. 3 D, right), suggesting that ssDNA 
was generated. Interestingly, Chk2 phosphorylation at ATM phos-
phorylation site T68 was not detected until the 24-h time point, 
when rereplication was initially detected. At the same time point, 
H2AX was phosphorylated, suggesting that DSBs were likely 
generated relatively late. When ATR was inactivated in U2OS 
cells by shRNA, the kinetics of Chk1, Chk2, and H2AX phos-
phorylation was altered. Chk1 phosphorylation was delayed be-
cause of the critical role of ATR to phosphorylate Chk1, whereas 
ATM-mediated Chk2 and H2AX phosphorylation as well as 
RPA chromatin loading occurred earlier (Fig. S3). This is con-
sistent with the idea that rereplication is more profound in ATR-
defi  cient cells, which leads to more severe DNA lesions and 
checkpoint activation. These data also suggest that the temporal 
order of the accumulation of phosphorylated species of Chk1 
and 2 and H2AX observed in ATR-profi  cient cells (Fig. 3 D) is not 
likely caused by different sensitivities of the specifi  c antibodies.
Collectively, these data suggest that ATR is activated before 
ATM at an early stage when Cdt1 is overexpressed, and ssDNA, 
which accumulates before DSBs, likely serves as an early signal 
to activate ATR. The activation of ATR at an early stage after 
Cdt1 overexpression but before signifi  cant rereplication is induced 
is consistent with the observation that ATR plays an important 
role in preventing rereplication.
The S phase checkpoint mediates ATR 
activation and prevents DNA rereplication
The observation of ssDNA accumulation at early stages after 
Cdt1 overexpression suggests that ATR is likely activated by 
the same S phase checkpoint pathway as when replication forks 
are stalled by DNA-damaging agents. Indeed, we observed that 
Rad17 was phosphorylated on chromatin, and Rad9 chroma-
tin loading was promoted when Cdt1 was overexpressed in 
multiple cell lines, including the cell lines without signifi  cant 
rereplication (Fig. 4 A). In addition, Cdt1 overexpression–
induced Chk1 phosphorylation was diminished when the ex-
pression of ATR-interacting protein (ATRIP) or Rad17 was 
inhibited by shRNA (not depicted). Meanwhile, inhibition of 
Rad17 or ATRIP expression caused more severe rereplication 
in U2OS cells and led to rereplication in A549 cells, which 
were otherwise resistant to Cdt1-induced rereplication (Fig. 4 B). 
These data demonstrate a critical role of the ATR-mediated 
S phase checkpoint pathway in both sensing the loss of licens-
ing control and preventing rereplication, which highlights a 
new aspect of the S phase checkpoint in the maintenance of 
genome stability.
DNA unwinding by MCM proteins from 
relicensed origins contributes to the 
accumulation of ssDNA
It is important to understand how ssDNA is accumulated at 
early stages after Cdt1 overexpression to activate ATR. To un-
derstand which steps of rereplication are involved in checkpoint 
activation, we sought to overexpress Cdt1 after S phase so that 
we could inhibit different steps of rereplication without interfer-
ing with normal S phase replication.
U2OS cells were synchronized by a double thymidine 
block. 6 h after releasing, nocodazole was added and after an-
other 6 h, almost all cells exited from S phase, as revealed by the 
cell cycle profi  le and low BrdU incorporation (Fig. S4 A, available 
Figure 4.  Rad17 and ATRIP are required 
for preventing Cdt1 overexpression–induced 
rereplication. (A) Chromatin was puriﬁ  ed from 
indicated cell lines 48 h after Ad-vec or Ad-Cdt1 
infection (T98G: 6 × 10
8 pfu/ml, MOI = 460; 
IMR90: 6 × 10
8 pfu/ml, MOI = 600; U2OS: 
5 × 10
7 pfu/ml, MOI = 25; A549: 6 × 10
8 
pfu/ml, MOI = 400). Western blot analyses 
were performed using antibodies recognizing 
Rad9, Rad17, and phosphorylated Rad17 at 
S645. (B) Rad17 and ATRIP were silenced by 
shRNA in U2OS and A549 cells. The protein 
levels of Rad17 or ATRIP were shown by Western 
blot analysis. FACS analysis was performed 
using indicated cell lines 48 h after Ad-vec or 
Ad-Cdt1 infection.S PHASE CHECKPOINT INHIBITS REREPLICATION • LIU ET AL. 649
at http://www.jcb.org/cgi/content/full/jcb.200704138/DC1; and 
not depicted). At this time point, cells were infected with 
Ad-Cdt1 or Ad-vec (Fig. 5 A). 24 h after adenoviral infection, 
both attached and round-up cells were collected after manually 
shaking off. Phosphorylation of Cdk1 at Tyr15 and cyclin A ex-
pression were detected in attached cells, and the mitotic marker 
phosphohistone H3 was present in shaken-off cells (Fig. S4 B), 
suggesting that a signifi  cant number of attached cells are in 
G2 phase, which is consistent with previous fi  ndings (Ballabeni 
et al., 2004). Cdt1 overexpression was predominantly observed 
in attached cells (Fig. S4 B), indicating that detached mitotic 
cells either were diffi  cult to infect or expressed Cdt1 at low levels. 
Attached cells were harvested for FACS analysis after Ad-Cdt1 
or Ad-vec infection and a signifi  cant amount of rereplication 
was induced after Ad-Cdt1 infection (Fig. 5 A). This Cdt1-
induced rereplication was prevented when adenoviruses encoding 
geminin, p27, or a Cdc7 KD mutant (Cdc7KD and Cdc7-D196N; 
Tsuji et al., 2006) were used to infect cells before Ad-Cdt1 in-
fection (Fig. 5 B), suggesting that Cdt1-mediated licensing and 
the kinase activity of Cdk and Cdc7 are required for rereplication 
induced after S phase. Cdt1-induced rereplication was also in-
hibited when cells were treated with aphidicolin, an inhibitor of 
DNA polymerase α (Fig. 5 B; Sheaff et al., 1991).
Similar to asynchronized cells, checkpoint was activated 
when Cdt1 was overexpressed after S phase (Fig. 5 A, bottom). 
Overexpression of geminin, p27, and Cdc7KD before Cdt1 pre-
vented ssDNA accumulation and attenuated checkpoint activa-
tion (Fig. 5 C). Interestingly, after aphidicolin treatment, although 
rereplication was prevented to similar levels as when p27 or 
Cdc7KD was overexpressed (Fig. 5 B), ssDNA accumulation 
shown by RPA1 chromatin loading was still evidently accompa-
nied by checkpoint activation (Fig. 5 C), although the level of 
checkpoint activation was reduced. These data suggest that the 
initiation of DNA rereplication, which requires Cdks and Cdc7 
activity, is important for generating ssDNA and activating 
checkpoint. Because aphidicolin inhibits DNA polymerase α 
and thus likely arrests replication/rereplication forks close to 
replication origins, continuous DNA synthesis and extensive re-
replication seem to not necessarily be required for ssDNA accu-
mulation and checkpoint activation, although they may possibly 
enhance these events.
When Cdt1/Cdc6 is overexpressed, MCM proteins are 
reloaded onto chromatin, but reloaded MCM proteins may not 
coordinate properly with other replication proteins. For in-
stance, MCM-mediated DNA unwinding may exceed the avail-
ability of polymerases that can be used to synthesize DNA when 
origins are refi  red. This may cause functional uncoupling of 
MCM helicase and DNA polymerases leading to the accumula-
tion of ssDNA, which has been described previously when DNA 
polymerase α is inactivated or the replication fork is stalled 
(Walter and Newport, 2000; Byun et al., 2005). If this model 
is correct, the MCM helicase activity that is required for DNA 
unwinding at the onset of rereplication would be needed for 
ssDNA accumulation and checkpoint activation upon Cdt1 
overexpression.
When p27 or Cdc7KD was overexpressed before Cdt1/
Cdc6 overexpression, we noticed that the loss of ssDNA accumula-
tion and checkpoint activation was accompanied by a decrease 
of MCM2 phosphorylation, as demonstrated by a decrease of 
the faster migrating band (the phosphorylated MCM2 species) 
on SDS-PAGE gel (Fig. 5 D). Because this cell cycle–regulated 
MCM2 phosphorylation is believed to be important for the helicase 
activities of the MCM complex (Tsuji et al., 2006), this fi  nding 
supports the idea that MCM-mediated DNA unwinding is involved 
in generating ssDNA.
To more directly examine whether DNA unwinding at re-
licensed origins was required for generating ssDNA, we inhib-
ited MCM helicase activity by overexpressing an MCM7 mutant 
(K387A) carrying a mutation at its conserved ATPase motif that 
is required for replication helicase activity (You et al., 1999; 
You et al., 2002). Immunoprecipitation showed that MCM7-
K387A interacted with other endogenous MCM proteins (not 
depicted) and that overexpression of this mutant prevented cells 
from entering S phase, suggesting a dominant-negative effect of 
this mutant (Fig. S5, available at http://www.jcb.org/cgi/content/
full/jcb.200704138/DC1). As shown in Fig. 5 E, overexpres-
sion of the MCM-K387A mutant before Cdt1 overexpression 
in   synchronized cells that had completed S phase inhibited re-
replication and signifi  cantly reduced RPA chromatin loading 
and Chk1 phosphorylation. These data strongly suggest that MCM-
mediated DNA unwinding from relicensed origins is required 
for generating ssDNA and activating the checkpoint when Cdt1 
is overexpressed.
ATR phosphorylates RPA2 and MCM2 
when Cdt1 is overexpressed
We have demonstrated that the ATR-mediated checkpoint can 
be activated by the initial steps of rereplication, which acts to 
prevent further rereplication. What is the mechanism by which 
activated ATR inhibits rereplication? We observed that RPA2, 
which plays essential roles in replication initiation and elonga-
tion (Binz et al., 2004; Fanning et al., 2006), was phosphorylated 
when Cdt1 was overexpressed (Fig. 3 A) in an ATR- but not 
ATM-dependent manner (Fig. 6 A, left). Similarly, phosphory-
lation of MCM2 at S108, a site phosphorylated by ATR upon 
UV and hydroxyurea treatment (Cortez et al., 2004), was also 
observed after Cdt1 overexpression (Fig. 6 A, right).
Multiple damage-inducible and ATR-dependent phosphory-
lation sites have been identifi  ed at the N terminus of RPA2 
(Zernik-Kobak et al., 1997; Nuss et al., 2005; Olson et al., 2006). 
Cdt1 overexpression–induced RPA2 phosphorylation was com-
pletely abolished in the HA-tagged RPA2 mutant carrying S/T-
to-A substitutions at the ATR-dependent phosphorylation sites 
S4/S8/S11-13/T21/S33 (Fig. 6 B, right;  Olson et al., 2006). 
Meanwhile, rereplication was also signifi  cantly enhanced in the 
cell line expressing the HA- RPA2-phospho mutant with en-
dogenous RPA2 silenced by shRNA compared with the cell line 
expressing the HA- RPA2 wild type (Fig. 6 B, left). These re-
sults suggest that ATR-mediated RPA2 phosphorylation plays a 
direct role in suppressing DNA rereplication. Because MCM2 
S108 is not the only ATR site and not all ATR phosphorylation 
sites on MCM2 have been identifi  ed (Cortez et al., 2004), a direct 
role of MCM2 phosphorylation by ATR in the suppression of 
rereplication is currently diffi  cult to analyze.JCB • VOLUME 179 • NUMBER 4 • 2007  650
Figure 5.  ssDNA accumulation is likely caused by aberrant DNA unwinding mediated by MCM proteins after Cdt1 overexpression. (A) U2OS cells were 
synchronized by double thymidine block and 25 ng/ml nocodozole was added into the medium 6 h after releasing. After another 6 h, cells were infected 
with Ad-vec or Ad-Cdt1 (3 × 10
8 pfu/ml, MOI = 75) or nothing. After shaking-off of mitotic cells, attached cells were collected 24 h after infection for 
FACS and Western blot analyses using phospho-Chk1 (S317)– and phospho-Chk2 (T68)–speciﬁ  c antibodies. (B) U2OS cells were synchronized as 
  described in A. 12 h after releasing cells from thymidine block with the presence of 25 ng/ml nocodozole for the last 6 h, cells were infected with Ad-vec 
(vec), Ad-geminin (gem), Ad-p27 (p27), or Ad-Cdc7KD (Cdc7KD), or treated with 1 μg/ml aphidicolin (Aphi). 3 h after the ﬁ  rst adenoviral infection or 
aphidicolin treatment, cells were reinfected with Ad-vec or Ad-Cdt1 (3 × 10
8 pfu/ml, MOI = 75). After mitotic shaking-off, attached cells were collected 
24 h after the ﬁ  rst adenoviral infection. Cell cycle proﬁ  le was monitored by FACS analysis. (C) Chromatin and whole cell lysates were prepared from S PHASE CHECKPOINT INHIBITS REREPLICATION • LIU ET AL. 651
Rb plays an important role in the 
prevention of rereplication
Overexpression of Cdt1 or Cdt1/Cdc6 can readily induce re-
replication in H1299 and U2OS cells. Because checkpoint acti-
vation is intact in these two cell lines, the defects in suppressing 
rereplication are probably present at downstream steps. As de-
scribed previously, the susceptibility of H1299 cells to rerepli-
cation is caused by a loss of p53 function (Vaziri et al., 2003). 
However, the U2OS cell line carries wild-type p53, and its 
  genetic basis for permitting rereplication is not clear.
A defect in Rb dephosphorylation was observed in U2OS 
cells during progression from mitosis into G1 (Broceno et al., 
2002). Upon DNA damage, Rb dephosphorylation is induced 
(Linke et al., 1997; Martelli and Livingston, 1999; Lan et al., 
2002; Avni et al., 2003). To examine whether a dephosphory-
lation defect of Rb in U2OS cells might contribute to Cdt1-
  induced rereplication, we used a U2OS cell line that expressed 
constitutively active Rb under the control of tetracycline (Chew 
et al., 1998; Broceno et al., 2002). In this Rb mutant, 14 of the 15 
conserved Cdk consensus sites are mutated. Cdt1 overexpression–
induced rereplication was significantly inhibited when the 
expression of hypophosphorylated Rb was induced (Fig. 6 C, 
top). These data suggest that a defect in U2OS cells affecting 
Rb dephosphorylation is likely responsible for permitting Cdt1-
induced rereplication. Consistent with an important role of 
Rb in the suppression of rereplication, when the expression 
of Rb was inhibited by shRNA in T98G and A549 cells, sub-
stantial rereplication was observed after Cdt1 overexpression 
(Fig. 6 C, bottom).
To assess whether overexpression of Cdt1 leads to Rb de-
phosphorylation and thus inhibition of rereplication, we moni-
tored Rb dephosphorylation by using the antibody G99-549, 
which specifi  cally recognizes the hypophosphorylated state of 
Rb after Cdt1 overexpression (Broceno et al., 2002; Avni et al., 
2003). In both IMR90 and A549 cell lines, Rb dephosphory-
lation was induced when Cdt1 was overexpressed (Fig. 6 D). 
  Interestingly, when ATR expression was inhibited by shRNA, 
accumulation of hypophosphorylated Rb species was dimin-
ished after Cdt1 overexpression. Collectively, these data sug-
gest that ATR-mediated checkpoint activation induces Rb 
dephosphorylation, which is involved in the inhibition of re-
replication induced by Cdt1 overexpression.
Both ATM and ATR contribute to the 
activation of the G2/M checkpoint induced 
by Cdt1 overexpression
Although both the ATM and ATR pathways are activated when 
Cdt1 is overexpressed, only the ATR pathway is necessary for 
the suppression of rereplication. What is the biological role of 
ATM activation? Previous papers have shown that Cdt1 over-
expression activates the G2/M checkpoint by arresting cells before 
mitosis and that ATR contributes to this arrest (Vaziri et al., 2003; 
Zhu and Dutta, 2006). As illustrated in Fig. 7, after Cdt1 over-
expression, cells expressing ATM-shRNA were also partially im-
paired in G2/M arrest as were ATR-shRNA–expressing cells, 
whereas simultaneous inhibition of both ATM and ATR further 
increased the number of cells that escaped G2/M arrest. Thus, 
ATR activation at an early stage after Cdt1 overexpression directly 
inhibits DNA rereplication and ATM is subsequently activated, 
which acts synergistically with ATR to arrest cells in G2/M.
Discussion
In this study, we demonstrated that the ATR-mediated S phase 
checkpoint provides a protection mechanism beyond licensing 
control to prevent rereplication and maintain genome stability. 
We also demonstrated that in mammalian cells, one initial sig-
nal to trigger checkpoint activation by Cdt1 overexpression is 
ssDNA accumulation, which is caused by uncontrolled MCM-
mediated DNA unwinding, whereas DSBs are generated sub-
sequently. This fi  nding suggests a novel mechanism to activate 
the checkpoint at the initiation of rereplication before uncon-
trolled rereplication occurs.
MCM-mediated DNA unwinding from 
relicensed origin is important for the 
activation of the checkpoint
The head-to-tail collision model illustrates the mechanism by 
which DSBs are generated during overt rereplication (Davidson 
et al., 2006). This model suggests that replication forks may 
chase one another when uncontrolled rereplication occurs, lead-
ing to fork collision and DNA fragmentation. However, in mam-
malian cells, the checkpoint can be activated in the absence of 
extensive DNA rereplication, suggesting that initiation of a lim-
ited amount of rereplication in mammalian cells is suffi  cient to 
activate the checkpoint. We also observed that in the presence of 
aphidicolin, the checkpoint is activated, although rereplication 
is effectively inhibited. Because rereplication forks are arrested 
in the presence of aphidicolin, replication and rereplication forks 
should not actively encounter each other and the initial signals 
that activate the checkpoint in mammalian cells are not likely 
generated by head-to-tail fork collision as in the X. laevis cell 
free system (Davidson et al., 2006). Another mechanism involving 
certain steps at the onset of rereplication is likely used to initiate 
checkpoint activation in mammalian cells.
Suppression of Cdk or Cdc7 activity abrogates ssDNA ac-
cumulation and checkpoint activation when rereplication is in-
duced after S phase, suggesting that the reassembly of pre-RC 
per se is not suffi  cient for checkpoint activation and that the ini-
tiation of DNA rereplication is required. Further studies demon-
strated that the inhibition of MCM helicase activities before Cdt1 
overexpression prevents ssDNA accumulation and checkpoint 
attached cells at the same time points as when FACS was performed as described in B. Western blot analyses were performed using antibodies as indi-
cated. (D) Chromatin was puriﬁ  ed as described in C and Western blot analysis was performed using antibodies recognizing MCM2. MCM2p, phosphory  lated 
MCM2. (E) Synchronized U2OS cells as described in B were infected with Ad-vec or Ad-MCM7-K387A (3 × 10
8 pfu/ml, MOI = 75) 3 h before Ad-vec 
or Ad-Cdt1 infection (3 × 10
8 pfu/ml, MOI = 75). Chromatin and whole cell extracts were puriﬁ  ed 24 h after ﬁ  rst adenoviral infection. Western blot analyses 
were performed as indicated. Cell cycle proﬁ  le was monitored by FACS analysis.JCB • VOLUME 179 • NUMBER 4 • 2007  652
activation, which supports the notion that DNA unwinding by 
MCM proteins from relicensed origins is involved in generating 
ssDNA and activating the checkpoint.
DNA replication is a highly coordinated process, and re-
initiation of DNA replication within the same cell cycle disrupts 
this balance. When MCM proteins are reloaded onto chromatin, 
Figure 6.  RPA2, MCM2, and Rb are impor-
tant effector proteins downstream of ATR to 
  inhibit Cdt1-induced rereplication. (A) 48 h after 
Ad-vec or Ad-Cdt1 infection, chromatin was 
puriﬁ   ed from U2OS cells expressing shRNA-
ATR, shRNA-ATM, or vector MKO (left), or cell 
lysates were prepared from U2OS or IMR90 
cells (right). The adenovirus titers U2OS (5 × 
10
7 pfu/ml, MOI = 25) and IMR90 (6 × 10
8 
pfu/ml, MOI = 600) were used. After 1 h, 
50 J/m
2 UV treatment was used as a positive 
control for MCM2 phosphorylation. Western 
blot analyses were performed as indicated. 
RPA2p, phosphorylated RPA2; MCM2-pS108, 
phosphorylated MCM2 at S108. (B) U2OS 
cell lines expressing the HA-RPA2 wild type or 
HA-RPA2-phospho mutant (S4A/S8A/S11A/
S12A/S13A/T21A/S33A) with endogenous 
RPA2 silenced by shRNA were generated as 
described previously (Olson et al., 2006). FACS 
analyses were performed 48 h after Ad-vec or 
Ad-Cdt1 infection (5 × 10
7 pfu/ml, MOI = 25). 
Western blot analyses were performed as indi-
cated. endo-RPA2, endogenous RPA2; HA-RPA2p, 
phosphorylated HA-tagged RPA2. (C) U2OS 
cells carrying tetracycline-regulated constitu-
tively active Rb were infected with Ad-vec or 
Ad-Cdt1 (5 × 10
7 pfu/ml, MOI = 25) in the 
presence of tetracycline (+tet, un-Rb off) or 24 h 
after removal of tetracycline (−tet, un-Rb on). 
36 h after infection, cell cycle proﬁ  les were 
monitored by FACS analysis (top). Rb was 
silenced in A549 and T98G cells by expressing 
shRNA from retroviral vector MKO. FACS analy-
sis was performed 48 h after Ad-vec or Ad-Cdt1 
infection (bottom; A549: 6 × 10
8 pfu/ml, 
MOI = 400; T98G: 6 × 10
8 pfu/ml, MOI = 
460). (D) Cell lysates were prepared from 
IMR90 or A549 cells expressing ATR-shRNA or 
vector MKO 20 or 40 h after Ad-vec or Ad-Cdt1 
infection (6 × 10
8 pfu/ml; IMR90, MOI = 
600; A549, MOI = 400). Rb phosphorylation 
was analyzed by the antibody G99-549, which 
speciﬁ  cally recognizes nonphosphorylated S608 
species. Ku80 was used as a loading control.S PHASE CHECKPOINT INHIBITS REREPLICATION • LIU ET AL. 653
MCM-mediated DNA unwinding may exceed the rate or capac-
ity of DNA polymerases to synthesize DNA, leading to ssDNA 
accumulation. It is known that primases synthesize RNA prim-
ers at a relative slow rate (Sheaff and Kuchta, 1993; Swart and 
Griep, 1995). DNA polymerases for lagging strand synthesis 
are limited (Langston and O’Donnell, 2006). Replication pro-
teins, such as MCM10 and DNA polymerase α/primase (Nasheuer 
et al., 1991; Izumi et al., 2001), are often phosphorylated during 
the cell cycle, and such modifi  cations may serve to suppress 
their replication activities at an inappropriate time. The uncou-
pling of MCM helicase and polymerase activities was proposed 
as an important mechanism leading to the generation of ssDNA 
when replication forks are stalled by DNA-damaging agents 
(Walter and Newport, 2000; Byun et al., 2005). Our data sug-
gest that the initiation of rereplication uses similar uncoupling 
mechanisms to activate checkpoint control, thereby providing a 
molecular explanation of how the conventional ATR-mediated 
S phase checkpoint is activated upon loss of licensing control.
Based on our fi  ndings, we propose that Cdt1 overexpres-
sion leads to reassembly of pre-RCs and that unscheduled DNA 
unwinding from relicensed origins by MCM proteins is uncou-
pled from DNA synthesis, leading to ssDNA accumulation and 
ATR activation (Fig. 8). DSBs generated subsequently are prob-
ably caused by the collapse of stalled rereplication forks.
Although in mammalian cells head-to-tail fork collision 
may not be the primary cause for checkpoint activation, uncon-
trolled rereplication induced by Cdt1 in the absence of an intact 
checkpoint control, as seen in U2OS or H1299 cells, could lead 
to fork collision and generate more DNA lesions. Therefore, the 
DNA unwinding model and the head-to-tail fork collision model, 
respectively, address the mechanisms underlying checkpoint ac-
tivation at the initial stage of rereplication and when rereplication 
occurs for multiple rounds. During uncontrolled rereplication, in 
addition to fork collision as described previously (Davidson 
et al., 2006), DSBs may also be generated when new rereplication 
forks encounter Okazaki fragments at the existing forks (Fig. 8).
The ATR-mediated checkpoint acts 
to prevent rereplication when licensing 
control is impaired
Although both ATR and ATM pathways are activated by Cdt1 
overexpression, our studies suggest that the ATR but not the ATM 
pathway is essential to prevent rereplication when the licensing 
control is compromised. ATR is activated earlier than ATM, be-
fore rereplication is detected. This quick response implies that 
ATR detects abnormal chromosomal structures generated at the 
initial steps of rereplication and suppresses rereplication immedi-
ately after it is activated. The inhibition of rereplicaion can be 
achieved by suppressing DNA rereplication initiation from other 
origins or elongation at existing rereplication forks. ATM, how-
ever, is activated at a much later stage, presumably as a conse-
quence of processing of the initial lesions that generate DSBs.
Inhibition of DNA rereplication by the ATR-mediated 
S phase checkpoint is essential for the prevention of genome 
  instability. During a normal cell cycle, mistakes may occur to 
allow reassembly of pre-RCs at one or more origins. Inhibition 
of rereplication immediately after DNA unwinding would pre-
vent rereplication forks from running into existing forks to gen-
erate DNA fragments, which can be highly recombinogenic and 
cause chromosomal rearrangement. This inhibition would also 
limit rereplication to a minimal extent, possibly right after the 
synthesis of RNA/DNA primers or small stretches of DNA at 
origins, so that checkpoint-activated repair pathways would 
be capable of effectively removing these duplicated sequences. 
It has been described that Rad51 is recruited to repair rereplication-
associated lesions (Zhu and Dutta, 2006). The G2/M checkpoint 
activated by ATR ensures that DNA lesions are repaired and a 
normal licensing control is reestablished before cells reenter 
the cell cycle. In contrast, when the loss of licensing control 
persists or is chronic, as under our experimental conditions or 
because of somatic mutations, rereplication forks are stalled 
by the continuous reloading of MCM proteins. Secondary DNA 
lesions, such as DSBs, are generated by fork collapse, activating 
ATM. Under such conditions, ATM activation is important for 
repairing DSBs and maintaining G2/M arrest until DNA lesions 
are repaired.
Multiple downstream effector pathways are 
activated to suppress rereplication
We demonstrate that rereplication is suppressed by the ATR-
mediated S phase checkpoint pathway and that multiple ATR 
downstream effector proteins appear to be involved in mediat-
ing this suppression. Thus, susceptibility to rereplication can be 
caused by various mutations in multiple pathways downstream 
of ATR, which provides a molecular basis for the difference in 
rereplication among different mammalian cell lines when licensing 
control is disrupted.
Both RPA2 and MCM2, two proteins essential for repli-
cation, were phosphorylated at ATR-dependent phosphory-
lation sites after Cdt1 overexpression. Mutating RPA2 N-terminal 
damage-inducible phosphorylation sites led to signifi  cant re-
replication when the licensing control was impaired. Damage-
induced RPA2 phosphorylation at these sites is proposed to prevent 
RPA from migrating into replication centers in S phase, thus 
Figure 7.  Down-regulation of ATR and/or ATM impairs G2/M check-
point in response to Cdt1 overexpression. Immunostaining using anti–
phosphohistone H3 (mitotic maker) antibodies was performed 48 h after 
Ad-vec or Ad-Cdt1 infection (5 × 10
7 pfu/ml, MOI = 25) in U2OS cells 
expressing vector MKO, shRNA-ATR, shRNA-ATM, or both shRNA-ATR and 
shRNA-ATM. In each experiment, >300 cells were counted. SD was derived 
from three independent experiments.JCB • VOLUME 179 • NUMBER 4 • 2007  654
attenuating the replication function of the RPA complex (Vassin 
et al., 2004; Olson et al., 2006). The phosphorylation of MCM 
proteins at the ATR consensus sites (Cortez et al., 2004) may also 
directly inhibit MCM functions required for DNA replication.
Besides targeting the replication machinery directly, ATR 
also inhibits rereplication indirectly through regulating requi-
site proteins that link checkpoints with cell cycle progression. 
p53 was proposed to inhibit rereplication through the p53–p21–
Cdk pathway upon checkpoint activation (Vaziri et al., 2003). 
In this study, we identifi  ed Rb as another downstream effector 
protein in the ATR pathway and showed that a defect in Rb func-
tion is the cause for the susceptibility of U2OS cells to Cdt1 over-
expression–induced rereplication.
Hypophosphorylated Rb binds to the E2F/DP family pro-
teins and sequesters their transcription activities (Harbour 
and Dean, 2000). Cdks, cyclins, and several replication proteins 
such as DNA polymerase α, ORC1, MCM proteins, Cdc6, and 
Cdt1 are E2F-regulated genes (Ohtani et al., 1996; Herwig and 
Strauss, 1997; Helin, 1998; Leone et al., 1998; Yan et al., 1998; 
Yoshida and Inoue, 2004). In addition, Rb directly interacts 
with replication proteins such as MCM7, DNA polymerase α, 
and replication factor C (Takemura et al., 1997; Sterner et al., 
1998; Pennaneach et al., 2001; Gladden and Diehl, 2003). Recent 
studies also demonstrated that DNA damage induces Rb dephos-
phorylation, and hypophosphorylated Rb binds to replication 
origin proximal sites specifi  cally after DNA damage (Linke 
et al., 1997; Martelli and Livingston, 1999; Lan et al., 2002; Avni 
et al., 2003). Thus, hypophosphorylated Rb likely inhibits 
DNA replication through multiple mechanisms (Knudsen et al., 
1998; Angus et al., 2004). Although Rb dephosphorylation was 
described after DNA damage, we further clarifi  ed the mechanism 
of this checkpoint response by showing that Rb dephosphory-
lation is under the control of ATR. We postulate that the accu-
mulation of hypophosphorylated Rb species is caused by Cdk 
down-regulation when the ATR-mediated S phase checkpoint 
is activated.
DNA rereplication can be a major driving force for genome 
amplifi  cation and genetic instability, which are highly associated 
with cancer development. We suggest that multiple effector 
pathways downstream of ATR, including Rb, are used to effec-
tively suppress rereplication in mammalian cells when licensing 
control is impaired. Both p53 and Rb are tightly linked to  cancer 
prevention. Therefore, our studies highlight a new aspect of 
S phase checkpoint control in the maintenance of genome sta-
bility and suppression of tumorigenesis through its critical role 
in the prevention of rereplication.
Materials and methods
Cell culture and retroviral infection
U2OS, H1299, A549, T98G, and IMR90 cells were grown in DME 
  supplemented with 10% fetal bovine serum. To induce the expression of 
Flag-ATR wild type or Flag-ATR-KD in the established U2OS cell lines 
(Nghiem et al., 2002), 1 μg/ml doxycycline was added to the media for 
24 h. U2OS cells with tetracycline-regulated constitutive active Rb (pro-
vided by S. Mittnacht, Institute of Cancer Research, London, UK; Chew 
et al., 1998) were maintained in medium, supplemented with 2 μg/ml 
tetracycline, 300 μg/ml G418, and 0.5 μg/ml puromycin. Rb expression 
was induced by culturing cells in tetracycline-free medium for 24 h.
Stable U2OS cell lines expressing an HA-tagged RPA2 or phospho-
RPA2 mutant were generated by retroviral infection using pBabe vector as 
described previously (Olson et al., 2006). Silencing of endogenous RPA2 
in these cells was conducted by two rounds of retroviral infection using a 
Figure 8.  Possible mechanisms leading to 
the generation of DNA lesions when Cdt1 is 
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pMKO vector (Masutomi et al., 2003) that expresses the RPA2 shRNA tar-
get sequence located in the 3′ untranslated region of the mRNA, followed 
by drug selection (Vassin et al., 2004). Other retroviral infection was also 
performed accordingly.
Whole cell lysate and chromatin isolation
Cells were lysed in NETN (150 mM NaCl, 1 mM EDTA, 20 mM Tris-Cl, 
pH 8.0, and 0.5% NP-40) containing protease and phosphatase inhibitors 
(Sigma-Aldrich). For chromatin isolation, cells were washed with PBS, re-
suspended in CSK buffer (10 mM Pipes, pH 6.8, 100 mM NaCl, 300 mM 
sucrose, 3 mM MgClB2, 1 mM EGTA, 50 mM Na-F, 0.1 mM Na-orthovan-
adate [Sigma-Aldrich], 0.1% Triton X-100 [Sigma-Aldrich], and protease 
inhibitors), and incubated on ice for 10 min. Cytoplasmic proteins were 
separated from nuclei by low speed centrifugation at 1,300 g for 5 min. 
Isolated nuclei were washed once in CSK buffer and lysed in solution 
(3 mM EDTA, 0.2 mM EGTA, 1mM DTT, and protease inhibitors). After 
centrifugation (1,700 g for 5 min), pellets were resuspended in CSK buffer. 
2× SDS loading buffer was added and samples were boiled for 10 min.
Plasmids
shRNA retroviral plasmids were constructed by inserting annealed shRNA 
oligos into a pMKO retroviral vector (Masutomi et al., 2003). The shRNA 
sequences used were ATM (G  C  A  C  C  A  G  T  C  C  A  G  T  A  T  T  G  G  C  T  T   and A  A  C  A  T  A-
C  T  A  C  T  C  A  A  A  G  A  C  A  T  T  ), ATR (C  G  A  G  A  C  T  T  C  T  G  C  G  G  A  T  T  G  C  A  G   and A  A  C-
C  T  C  C  G  T  G  A  T  G  T  T  G  C  T  T  G  A  ; Casper et al., 2002), ATRIP (A  A  G  G  T  C  C  A  C  A-
G  A  T  T  A  T  T  A  G  A  T  ; Ball et al., 2005), Chk2 (C  A  G  T  G  T  C  C  A  C  T  C  A  G  G  A  A  C  T  C  T  ), 
Chk1 (A  A  G  C  G  T  G  C  C  G  T  A  G  A  C  T  G  T  C  C  A   and A  A  G  T  A  C  T  C  C  A  G  T  T  C  T  C  A  G-
C  C  A  ), claspin (C  C  T  T  G  C  T  T  A  G  A  G  C  T  G  A  G  T  C  T  T   and G  G  A  A  A  G  A  A  A  G  G  C  A-
G  C  C  A  G  A  T  T  ; Chini and Chen, 2003), Rad17 (C  A  G  A  C  T  G  G  G  T  T  G  A  C  C  C  A-
T  C  T  T ; Zou et al., 2002), DDB1 (T  G  A  G  T  G  C  T  T  G  A  C  A  T  A  C  C  T  T  G  A  ), and Cdt2 
(G  T  T  C  C  T  G  G  T  G  A  A  C  T  T  A  A  A  C  T  T  ; Jin et al., 2006). Sequence information 
for Chk1 and 2 shRNA was provided by A. Maclaren, J. Scorah, and 
C. McGowan (The Scripps Research Institute, La Jolla, CA).
To obtain the MCM7-K387A mutant, site-directed mutagenesis was 
conducted by QuickChange mutagenesis (Stratagene) using full-length MCM7 
as a template. The oligonucleotides 5′-C  T  G  A  T  G  G  G  G  G  A  T  C  C  T  G  G  T  G  T  G  G-
C  C  G  C  G  T  C  T  C  A  G  C  T  C  C  T  G  T  C  A  T  A  C  A  T  T  G  A  T  -3′ and 5′-A  T  C  A  A  T  G  T  A  T  G  A  C  A-
G  G  A  G  C  T  G  A  G  A  C  G  C  G  G  C  C  A  C  A  C  C  A  G  G  A  T  C  C  C  C  C  -ATCAG-3′ were used 
as primers.
The Cdc7KD was generated by mutating D196 to N in the con-
served kinase motif of Cdc7 (Tsuji et al., 2006).
Adenovirus construction and infection
Adenoviruses encoding GFP, human Cdt1, Cdc7KD, Cdc6, and MCM7-
K387A were generated by using the AdEasy system (He et al., 1998). 
In brief, the target cDNAs were constructed into a pAd-track-CMV shuttle 
vector and in vivo recombination was performed by transforming the pAd-
track-CMV shuttle vector together with the pAd-Easy-1 adenoviral vector 
into a BJ5813 competent cell by electroporation. The recombinant adeno-
viral plasmids were transfected into 293 cells to produce corresponding 
recombinant adenoviruses. Large-scale puriﬁ  cation of viruses was obtained 
by CsCl density gradient centrifugation. Recombinant adenoviruses encod-
ing p27 and geminin were provided by S. Reed (The Scripps Research 
  Institute, La Jolla, CA) and J. Cook (University of North Carolina at Chapel 
Hill, Chapel Hill, NC).
To enrich cells that have completed S phase, U2OS cells were syn-
chronized by double thymidine block (2 mM thymidine for 16 h and no 
thymidine for 12 h). 6 h after being release from the second thymidine 
block, 25 ng/ml nocodozole was added to the media, and after another 
6 h, cells were infected with adenoviruses. After mitotic shaking-off, attached 
cells were collected for further analysis.
 Infection of T98G cells in G0 was performed by culturing cells 
in a medium containing 0.1% fetal bovine serum for 24 h, followed by 
adenoviral infection of Ad-vec or Ad-MCM7-K387A. 24 h after adenoviral 
infection, cells were released from G0 by adding 10% fetal bovine serum 
into medium.
Immunoﬂ  uorescence staining and antibodies
To examine G2/M arrest, cells were ﬁ   xed with 4% paraformaldehyde, 
permeabilized with 0.5% Triton X-100 in PBS, and stained with antibodies 
recognizing phosphohistone-H3 (the mitotic marker), followed by DNA 
staining with DAPI. For measuring ssDNA formation, cells were labeled 
with 10 μM BrdU for 24 h after adenoviral infection. Cells were ﬁ  xed, per-
meabilized, and stained with anti-BrdU antibodies.
The following antibodies were used in this study: Cdt1 was produced 
as described previously (Li et al., 2003); the phospho-Chk1 (S317) antibody 
was obtained from R&D Systems; phospho-Chk2 (T68) was obtained from 
Cell Signaling Technology; Chk1, Chk2, Ku70, Rad17, Rad9, and geminin 
antibodies were obtained from Santa Cruz Biotechnology, Inc.; p27, actin, 
RPA1, RPA2, ATM, and ATR antibodies were obtained from EMD; γ-H2AX 
and phosphohistone H3 antibodies were obtained from Millipore; ATRIP 
and phospho-MCM2 (S108) antibodies were obtained from Bethyl Labora-
tories, Inc.; Rb, cyclinA, cyclinE, MCM2, and DDB1 antibodies were ob-
tained from BD Biosciences. Cdc7 antibody was provided by T. Tsuji and 
W. Jiang (The Burnham Institute for Medical Research, La Jolla, CA).
FACS analysis
Cells were collected and ﬁ  xed with ice cold 70% ethanol overnight at 
4°C. After washing with PBS, cells were stained with 15 μg/ml propid-
ium iodide solution containing 38 mM sodium citrate and 10 μg/ml 
RNase A and analyzed on a ﬂ  ow cytometer (Becton Dickinson) using 
Cellquest software (BD Biosciences). For BrdU incorporation analysis, 
cells were pulse labeled with 10 mM BrdU for 1 h. After ﬁ  xation with ice 
cold 70% ethanol for 1 h, cells were resuspended in 2 mM HCl and in-
cubated for 20 min at room temperature. After centrifugation, cell pel-
lets were resuspended in 0.5 ml of 0.1 M Na2B4O7, pH 8.5, and after 
a PBS wash, cells were stained with 50 μl of antibody solution (30 μl 
PBS containing 0.5% Tween-20/0.5% BSA + 1 μl mouse anti-BrdU 
monoclonal antibody) for 1 h at room temperature, followed by 30-min 
staining with FITC-conjugated secondary antibody in the dark before 
propidium iodide staining.
Online supplemental material
Fig. S1 shows that overexpression of Cdt1 or Cdt1/Cdc6 induces DNA re-
replication in certain tumor cell lines. Fig. S2 shows that Cdt1 overexpres-
sion and Chk1 phosphorylation were detected earlier when a higher titer 
of Ad-Cdt1 was used. Fig. S3 shows a time course analysis of checkpoint 
activation and RPA chromatin loading in ATR-deﬁ  cient or -proﬁ  cient cells 
after Cdt1 overexpression. Fig. S4 shows that U2OS cells were synchro-
nized to G2/M. Fig. S5 shows that overexpresion of the MCM7-K387A 
mutant prevents S phase entry. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200704138/DC1.
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